A pilot study assessing the clinical utility of deep learning-reconstructed 3D-echo-planar-imaging-based quantitative susceptibility mapping in multiple sclerosis
Our results constitute a first demonstration of the enhanced quality and clinical utility of the DLR-3DEPI-based QSM in MS.
Authors
- Nina de Oliveira S. Siebenborn
- Alessandro Cagol (ORCID: https://orcid.org/0000-0002-7703-0553)
- Josef Pfeuffer (ORCID: https://orcid.org/0000-0001-9887-0458)
- Matthias Weigel (ORCID: https://orcid.org/0000-0002-4910-1414)
- Esther Ruberte (ORCID: https://orcid.org/0000-0002-0195-4602)
- Dimitrios Gkotsoulias (ORCID: https://orcid.org/0009-0005-1584-1552)
- Cristina Granziera (ORCID: https://orcid.org/0000-0002-4917-8761)
Institutions
- University of Basel (CH)
- University Hospital of Basel (CH)
- Siemens Healthineers (Germany) (DE)
- University of Genoa (IT)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fnins.2025.1544376
- Primary Topic
- Advanced MRI Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Siemens Healthineers